Concepedia

Holly M. Alley

HM

9

Publications

723

Citations

9

H-Index

2011

Active since

Affiliations

Duke University(Current)

Howard Hughes Medical Institute

University of Illinois Urbana-Champaign

Holly M. Alley is an author at Duke University specializing in medicine, oncology, and drug discovery.

Top concepts

Publications per year

2011–2017

9

Publications

9

Systematic identification of signaling pathways with potential to confer anticancer drug resistance

Colin A. Martz, Kathleen Ottina, Katherine R. Singleton et al. · Science Signaling · 2014 · 197 citations · Full text

, , +23

Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast Cancer

Suzanne E. Wardell, Matthew J. Ellis, Holly M. Alley et al. · Clinical Cancer Research · 2015 · 153 citations · Full text

Evaluation of the pharmacological activities of RAD1901, a selective estrogen receptor degrader

Suzanne E. Wardell, Erik R. Nelson, Christina Chao et al. · Endocrine Related Cancer · 2015 · 111 citations · Full text

, , +18

Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer

John D. Norris, Stephanie J. Ellison, Jennifer G. Baker et al. · Journal of Clinical Investigation · 2017 · 58 citations · Full text

<i>PIK3CA</i> mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation

Grace R. Anderson, Suzanne E. Wardell, Lorin Crawford et al. · Science Translational Medicine · 2016 · 57 citations · Full text

Rows per page

1–5 of 9